Navigation Links
Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland
Date:12/3/2009

HELSINKI, December 3 /PRNewswire/ -- After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

A Phase II trial for the everyday treatment against obesity and the overeating of unhealthy food, by nasal spray and a behavioural programme, will aim to prove that Lightlake's treatment can break the addictive habit of unhealthy eating, significantly reduce weight, and train the mind to embark on a healthier dietary lifestyle and sustained weight-loss.

Obesity is an epidemic that is resulting in millions of preventable deaths worldwide. (1) The American Cancer Society estimates that over 100,000 Americans are dying from obesity and over eating related cancers every year and the estimated healthcare cost alone is $147 billion every year. (2)

By 2012, it's expected that more than two billion people will be overweight and 600 million will be obese. The U.S. Center for Disease Control and Prevention and Department of Health in the UK both estimate that 60% of men and 50% of women and 25% of children will be obese by 2050 if current trends continue. (3)

Lightlake has been given ethical approval to begin subject selection for Phase II clinical trial under the direction of its trial coordinator Professor Hannu Eero Rafael Alho, Professor of Addiction Medicine, University of Helsinki. The Trial is being conducted in conjunction with the National Institute for Health and Welfare, in Helsinki. It will last 6 months and results are expected in the fall of 2010.

Lightlake is pioneering the treatment of one of the world's biggest killers and will be initially focused on addres
'/>"/>

SOURCE Lightlake Therapeutics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis
2. Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities
3. Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
4. Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS
5. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
6. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
7. Echo Therapeutics to Present at the New York Society of Security Analysts 13th Annual Biotech and Specialty Pharmaceuticals Conference
8. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
9. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
10. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
11. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Calif. , Oct. 17, 2014  Amgen (NASDAQ: ... R. Sanders Williams , M.D., president of Gladstone ... Distinguished Professor.  "We are pleased to ... Board," said Robert A. Bradway , chairman and ... distinguished experience in academic medicine and his direct experience ...
(Date:10/17/2014)... 2014 According to ... Technique (Optical Coherence Tomography, Hyperspectral Imaging, Photoacoustic ... Neurology, Oncology, Cardiology) - Global Forecasts to ... Optical Imaging market over the forecast period ... $917.1 million in 2014 and is expected ...
(Date:10/17/2014)... 17, 2014 The following is being ... The Green Park Collaborative (GPC) will ... private payers, medical device and pharmaceutical companies, as ... January 12, 2015 at its first ever workshop ... loss treatments.  Participants will discuss study designs to ...
Breaking Medicine Technology:Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2
... Orthopedic Group, Inc. (NYSE: HGR ) today announced that ... private offering to qualified institutional buyers pursuant to Rule 144A under ... Regulation S under the Securities Act.  The notes were priced at ... expected to close on November 2, 2010. The notes ...
... Md. and INDIANAPOLIS, Oct. 20 MacroGenics, Inc. and ... today announced that the Protege Data Monitoring Committee (DMC), ... and biostatistics, has completed a planned analysis of one-year ... clinical trial of teplizumab, an investigational biologic under development ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes 2Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes 3MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
(Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
(Date:10/19/2014)... UNITED NATIONS, New York (PRWEB) October 19, 2014 ... the United Nations Population Fund, welcomes news of a ... release of the more than 200 girls who were ... Girls. "These girls have languished in captivity long enough, ... their families, schools and communities," stated Dr. Osotimehin. , ...
(Date:10/19/2014)... October 20, 2014 Having been working in ... good knowledge of customer needs. According to James, one of ... with dazzling sequins, or with high-low skirts that add beauty ... huge demand. Recently, LunaDress has unveiled its new selection of ... fact, the company’s brand new items are available in over ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that provides many ... latest designs of 2014 mother of the bride ... are offered with big discounts, up to 70% off. ... can enjoy this special offer. , Owing to ... become one of the leading brands in the global ...
(Date:10/19/2014)... NC (PRWEB) October 19, 2014 ... building program has just been released to the ... the online body building and fitness community. The ... attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative ... experience of hitting what is commonly known as ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... The spoils of war for returning veterans may include ... they witnessed. Now a University of Houston joint ... and Development service looks to address these issues through ... Graduate College of Social Work (GCSW) joins Baylor College ...
... (HealthDay News) -- Depression rates are higher in richer ... researchers who compared socioeconomic conditions with depression. About ... people,s quality of life by affecting their ability ... to suicide and causes 850,000 deaths every year. ...
... -- A person,s brain works hard to empathize or understand ... matter how different they may be, a new study indicates. ... automatically attempt to empathize -- even with those who are ... two separate regions of their brain. In a paper, ...
... FOR JULY 26, 2011] Antibiotic overuse and resistance have ... Following an outbreak of Clostridium difficile infections, which often ... Canada targeted physicians and pharmacists with an education campaign ... published in Clinical Infectious Diseases and now ...
... ,Researchers have identified ... dilated cardiomyopathy (heart muscle disease), according to results from a ... (NHLBI) of the National Institutes of Health. Using ... children who will or will not benefit from life-saving transplantation ...
... MONDAY, July 25 (HealthDay News) -- The varicella vaccine has nearly ... study shows. The vaccine, introduced in a one-dose form ... all age groups and by 97 percent in young people 20 ... Immunization and Respiratory Diseases. "This is one of our ...
Cached Medicine News:Health News:Returning vets' alcohol abuse addressed in virtual reality study 2Health News:Depression Higher in Wealthier Nations 2Health News:Human Brains Wired to Empathize, Study Finds 2Health News:Simple guidelines decreased unnecessary antibiotic use in Quebec, Canada 2Health News:Study finds important risk factors for death/transplantation in children with heart muscle disease 2Health News:Chickenpox Vaccine May Wipe Out Related Deaths: Study 2Health News:Chickenpox Vaccine May Wipe Out Related Deaths: Study 3
... The 6060 MULTI-THERAPY Infusion ... of infusion profiles that ... reliable delivery. Designed for ... the 6060 MULTI-THERAPY Pump ...
... COLLEAGUE pumps can be customized with selectable ... care sites and therapies. The COLLEAGUE ... to be used for both gravity and ... costs. From simple infusions to medication therapies ...
... Pathology and Laboratory Medicine at the Cleveland ... most comprehensive academic medical center laboratories. With ... more than 40 pathologists and PhDs, our ... results, interpretations and diagnostic consultations annually. Our ...
Focus Diagnostics Reference Laboratory is known for quality infectious disease and autoimmune testing services. We offer over 1200 tests and panels and are continually adding new tests to our menu....
Medicine Products: